RIPK2 Antikörper (Middle Region)
Kurzübersicht für RIPK2 Antikörper (Middle Region) (ABIN926883)
Target
Alle RIPK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Rind (Kuh), Huhn
-
Aufreinigung
- Purified
-
Immunogen
- RIPK2 antibody was raised in rabbit using the middle region of RIPK2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
RIPK2 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this RIPK2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))
-
Andere Bezeichnung
- RIPK2
-
Hintergrund
- RIPK2 is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. It contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. Synonyms: Polyclonal RIPK2 antibody, Anti-RIPK2 antibody, receptor-interacting serine-threonine kinase 2 antibody, CARD3 antibody, CARDIAK antibody, CCK antibody, GIG30 antibody, RICK antibody, RIP2 antibody.
-
Pathways
- T-Zell Rezeptor Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades
Target
-